# OnCo record nct07814248 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07814248/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07814248", "NCT07814248" ;
  schema:name "A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors"@en ;
  schema:description "A phase 1 trial of TS-104 run by TwoStep Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07814248/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07814248> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/gastric/> ;
  onco:drugs <https://onco.cc/drugs/ts-104/> ;
  onco:companies <https://onco.cc/companies/twostep-therapeutics/> .